Article
Which, and how limited number of polymorphisms should be selected per disease, risk assessment, health profile or biological system?
Clinical chemistry and laboratory medicine - 1 Apr 2003
Masana L, Madan T, Visvikis S, Sass C, Baranova H, Bonnet J, Dembinska A, Ehrlich H, Gueyffier F, Schmitz G, Siest G, Zannis V
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.